Testing a new under-the-tongue med for alcohol use and trauma
Part of Mental health clinical trials.
This study tests a new sublingual (under-the-tongue) medication for people with alcohol use disorder who have also had a traumatic life event. It aims to see if the medication can help reduce drinking and related symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 21 and 65 years old.
- You must have a diagnosis of alcohol use disorder (mild, moderate, or severe).
- You must have had at least one heavy drinking episode (more than 4 drinks for men, 3 for women) in the past 30 days.
- You must have experienced a traumatic event in your life and have some trauma-related symptoms.
- You cannot be taking certain medications, including those for alcohol use, sedatives, blood pressure meds, or some antidepressants.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special brain scan (PET) to look at a protein called PDE4B in people with PTSD or alcohol use disorder. It may help researchers understand these conditions better.
This study tests an investigational drug (pregnenolone) to see if it can help veterans who have both PTSD and alcohol use disorder. The goal is to find the right dose that might reduce stress-related drinking.
This study tests whether the sleep medication suvorexant can help people with both alcohol use disorder and PTSD. If you're struggling with drinking, PTSD symptoms, and poor sleep, this trial may offer a new treatment option.
This study tests a small earpiece that sends gentle pulses to a nerve in your ear, which may help calm the body's stress response. It aims to see if using this device for a few minutes each day can help firefighters cut down on heavy drinking linked to stress.
This trial tests if a single infusion of allopregnanolone (a natural brain chemical) can help people with PTSD reduce fear responses and improve memory processing. It may offer a new way to treat PTSD by targeting how the brain stores traumatic memories.
This Phase 2 study tests whether blood/brain “biomarkers” can help choose a treatment plan for people who have alcohol use disorder and PTSD. The goal is to improve outcomes related to drinking and PTSD symptoms compared with a standard approach.
Hear when a new Alcohol Use Disorder (AUD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.